Michael Eder, MA, is Senior Marketing Manager at Single Use Support. He is expert in pharma and health communication with his 10+ years experience in pharma. After completing his master's degree in International Healthcare Management at MCI The Entrepreneurial school in Innsbruck, he has gained experience in the pharmaceutical field manufacturing and commercialization of OTC and RX drugs. Michael creates articles about Freeze Thaw applications and Platform solutions from Single Use Support and is the author of current news with Single Use Support worldwide.
Articles written by Michael Eder
News
Single Use Support honoured as one of the ‘Best Managed Companies’
Deloitte Austria and Raiffeisenlandesbank Niederösterreich-Wien have honoured outstandingly managed companies. Single Use Support was the only winner from Tyrol to be honoured with the title ‘Best Managed Company 2024’.
Michael Eder
September 30, 2024
News
Third consecutive Pharma Innovation Award for Single Use Support
RoSS.PADL, the homogenizing solution from Single Use Support, was awarded the 2024 Innovation Award by Pharma Manufacturing.
Michael Eder
September 26, 2024
Freeze & Thaw
Interview with NIBRT: Innovating Freezing & Thawing in Bioprocessing
The collaboration between Single Use Support and the National Institute for Bioprocessing Research and Training (NIBRT) exemplifies a shared commitment to advancing scientific knowledge and driving innovation in the bioprocessing industry.
Michael Eder
August 13, 2024
Vaccines
The development process of biosimilars
The development process of biosimilars slightly differs from the one of their reference biologics. In this article, we will discuss each phase in detail.
Michael Eder
May 13, 2024
Vaccines
Biomanufacturing: Process, steps and challenges in manufacturing biologics
As biologics have become a central pillar in today’s healthcare sector, their manufacturing process increasingly draws attention. In this article, we will discuss the process step by step, including challenges and possible ways to overcome them.
Michael Eder
May 13, 2024
Vaccines
Efficient strategies for manufacturing biosimilars
Establishing both efficient and safe manufacturing processes for biosimilars requires planning, expertise, and state-of-the-art equipment. In this article, we will shed light on different steps in the manufacturing process and discuss ways to improve them.
Michael Eder
May 8, 2024
Vaccines
An introduction to biosimilars
Biosimilars are a popular alternative to reference biologics they resemble. But what has led to this popularity, and what’s to know about their manufacturing? Find out in this article!
Michael Eder
May 8, 2024
Vaccines
Biologics: An introduction to biologic drugs
In the past few decades, biologics have become an integral pillar in healthcare worldwide. Deriving from living organisms, they hold huge therapeutic potential, with many possible applications still undiscovered. In this article, we will give you an overview of this exciting class of pharmaceuticals.
Michael Eder
May 8, 2024
Vaccines
Biologics vs. Biosimilars: What is the difference?
Biologics and biosimilars are both innovative and frequently used therapeutics, but where do they differ? They will be uncovered in this article.
Michael Eder
May 6, 2024
Vaccines
What are Active Pharmaceutical Ingredients (APIs)?
Active Pharmaceutical Ingredients (APIs) are the cornerstone of pharmaceutical drugs, serving as the primary agents responsible for delivering therapeutic effects to patients.
Michael Eder
March 21, 2024
News
Single Use Support joins Rx-360
Single Use Support is pleased to announce that it has recently become a member of Rx-360, the International Pharmaceutical Supply Chain Consortium.
Michael Eder
March 8, 2024
Fill & Filtration
Evolving Aseptic Filling in Biomanufacturing
Laminar flow hoods and biosafety cabinets were the stalwarts of aseptic processing, providing controlled environments for fluid transfer tasks. However, as the demand for sterile drug products escalated and regulatory standards tightened, the industry embarked on a quest for more robust and efficient methods. Automated filling platforms now reduce the risk of contamination and guide the way to reproducible aliquot consistency, filling accuracy and speed.
Michael Eder
March 7, 2024